06/10/2026
🐴 Got bad Hocks?🐴
Remember our Arthramid study? We are officially halfway through the year, and the doors are still open for new equine athletes to enroll!
If your horse is struggling with hock lameness, here is your quick refresher on why this study is a game-changer...
VetweRx is proud to announce a targeted clinical study focusing on the long-term resolution of Distal Hock Osteoarthritis (DIT & TMT joints). We are seeking horses currently struggling with joint lameness to evaluate the superior efficacy of Arthramid® Vet—a shift from temporary symptom masking to long-term joint restoration.
With this study we hope to provide an alternative for steroid maintenance injections, less cost in yearly injections and healthier athletes all around!
So, what is Arthramid Vet?
It’s not your average joint injection. Arthramid is a 2.5% polyacrylamide hydrogel—a biocompatible, non-degradable medical device. Unlike traditional steroids or HA that wear off quickly, Arthramid integrates into the joint lining to provide long-term relief and real healing.
What we are trying to prove…
✅ Superior Longevity: Lasts significantly longer than traditional corticosteroid injections.
✅ Restores Joint Health: It stabilizes the membrane and restores the horse’s natural joint fluid.
✅ Real Results: It doesn’t just mask pain; it improves the elasticity and health of the joint capsule itself.
What are the perks for participating?
We are offering major incentives for horses enrolled in the study:
40% OFF the normal cost of treatment.
Diagnostic Assurance: In the rare case of treatment failure, the company will cover the cost of a CT scan to help us get to the bottom of the issue.
Contact us here ⬇️
https://search.app/TMEo3vLuZQ3wxPB39
